Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
No Data
CDLX Transcript
Cardlytics, Inc. (CDLX) Q1 2026 Earnings Call Transcript
Unknown5-8
The earnings call reveals significant revenue and billings decline due to the loss of Bank of America, despite operational improvements. The guidance suggests continued revenue challenges, and macroeconomic pressures further impact key sectors. While there are positive aspects like U.K. growth and improved liquidity, the overall sentiment is negative due to declining financial metrics and risks, leading to a likely negative stock price movement in the next two weeks.
Cardlytics, Inc. (CDLX) Q4 2025 Earnings Call Transcript
Unknown3-4
The earnings call presents a mixed outlook. Positive indicators include increased EBITDA, positive cash flow, and strong UK market growth. However, the loss of a major partner, BofA, and content restrictions pose significant challenges. The company is optimistic about future growth with new partnerships and cost reductions, but uncertainties remain, particularly regarding MQUs and the full impact of BofA's exit. The Q&A reveals cautious optimism but lacks clarity on some issues, leading to a neutral sentiment prediction.
Cardlytics, Inc. (CDLX) Q3 2025 Earnings Call Transcript
Unknown11-5
The earnings call reveals significant challenges: a loss of a major FI partner, a 20.3% decline in billings, and a 22.4% drop in revenue. Despite some positive aspects, like improved adjusted EBITDA and U.K. growth, the dependence on new partnerships and economic uncertainties pose risks. The Q&A didn't alleviate concerns, as explanations confirmed ongoing margin pressures and uncertainties in guidance. These factors, along with the lack of a market cap, suggest a negative sentiment, anticipating a stock price decline of -2% to -8%.
Cardlytics, Inc. (CDLX) Q2 2025 Earnings Call Transcript
Unknown8-6
The earnings call reveals several negative indicators: a 9.2% revenue decline, decreased revenue to billings margin, and ongoing pressures on advertiser performance. Despite some positive elements like increased U.K. revenue and positive adjusted EBITDA, the Q&A highlights significant concerns about FI partner restrictions affecting billings and unclear management responses. The guidance for Q2 2025 further indicates a potential decline. These factors suggest a negative sentiment, likely resulting in a stock price decrease between -2% to -8% over the next two weeks.
CDLX Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
